RESEARCH-USE BIOSIMILAR ANTIBODY
Indusatumab
Monoclonal antibody · IgG1
Indusatumab (5F9 Monoclonal antibody) is a monoclonal antibody against human GUCY2C (Guanylate cyclase 2C). Indusatumab fails to bind to granulocytes or erythrocytes. Indusatumab can be used to synthesize ADCs, such as Indusatumab vedotin (HY-P99662). Indusatumab can be used in cancer research.
TARGETGUCY2C
YMonoclonal antibody
CATALOGSC-BS-483
CATALOG NUMBERSC-BS-483
MOLECULAR WEIGHTApprox. 145.206 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Indusatumab (5F9 Monoclonal antibody) is a monoclonal antibody against human GUCY2C (Guanylate cyclase 2C). Indusatumab fails to bind to granulocytes or erythrocytes. Indusatumab can be used to synthesize ADCs, such as Indusatumab vedotin (HY-P99662). Indusatumab can be used in cancer research.
Indusatumab is a recombinant research-use antibody directed against GUCY2C.